Characteristics of the studies
Study | N | Sample type | Optimism measure | Health measure | Study design | Effect size (r) |
---|---|---|---|---|---|---|
Studies with objective health measure | ||||||
Allison et al. (2003) [41] | 101 | Head and neck cancer | FLOT | Survival at 1 year | PR | .06 |
Brennan and Charnetski (2000) [42] | 112 | Undergraduates | ASQ | Immunoglobulin A | CS | −.02 |
Brody et al. (2008) [43] | 200 | Diabetes mellitus | LOT (pessimism) | Glycosylated hemoglobin | CS | .10 |
Cohen et al. (1999) [44] | 39 | Healthy women | LOT | Immune measure (mean of CD 4 counts of 3 months) | LO | .29 |
Cohen et al. (1999) [44] | 39 | Healthy women | LOT | Immune measure (mean of CD 8 counts of 3 months) | LO | .02 |
Cohen et al. (1999) [44] | 39 | Healthy women | LOT | Immune measure (mean of NK Cells counts of 3 months) | LO | −.03 |
Contrada et al. (2004) [45] | 142 | Surgery | LOT-R | Post-surgical complications | LO | .10 |
Costello et al. (2002) [2] | 20 | Temporomandibular disorder | LOT | Immune measure (IL-6) | PR | −.62 |
De Moor et al. (2006) [46] | 90 | Cancer | LOT-R | Cancer antigen (CA 125) | LO | −.32 |
de Ridder et al. (2004) [5] | 65 | Type I diabetes | LOT-R | Blood glucose | CS | −.15 |
Friedman et al. (1993) [47] | 1,178 | Aging | TC | Death | LO | −.09 |
Giltay et al. (2004) [48] | 940 | Aging | SWB | Survival | PR | .18 |
Goetzmnn et al. (2007) [49] | 76 | Transplant patients (lung, liver, or bone marrow) | LOT | Survival | PR | .005 |
Helgeson and Fritz (1999) [50] | 298 | Percutaneous transluminal coronary angioplasty | LOT | New coronary events (death from coronary artery disease, myocardial infarction, progression, etc.) | PR | .03 |
Kennedy and Hughes (2004) [51] | 50 | Healthy undergraduates | LOT-R | Systolic blood pressure reactivity | LO | .30 |
Kennedy and Hughes (2004) [51] | 50 | Healthy undergraduates | LOT-R | Diastolic blood pressure reactivity | LO | −.08 |
Kennedy and Hughes (2004) [51] | 50 | Healthy undergraduates | LOT-R | Heart rate reactivity | LO | 0 |
Kivimaki et al. (2005) [52] | 5,007 | Healthy people | LOT-R | Increase in number of sick days | PR | −.04 |
Kohut et al. (2002) [53] | 57 | Aging | LOT | Immune measure (IL-10) | LO | .24 |
Lee et al. (1995) [54] | 89 | Male Air Force cadets | LOT | Immune measure (PHA) | LO | .04 |
Lee et al. (1995) [54] | 89 | Male Air Force cadets | LOT | Immune measure (PMA) | LO | .11 |
Lee et al. (1995) [54] | 89 | Male Air Force cadets | LOT | Immune measure (anti-CD3) | LO | −.02 |
Lobel et al. (2000) [55] | 129 | Pregnancy | LOT | Birth weight | LO | .20 |
Lobel et al. (2000) [55] | 129 | Pregnancy | LOT | Gestational age | LO | .13 |
Maruta et al. (2000) [56] | 723 | Aging | MMPI (pessimism) | Death | PR | .09 |
Matthews et al. (2004) [57] | 209 | Healthy middle-aged women | LOT (pessimism) | Increase in carotid intima-media thickness | PR | .19 |
Matthews et al. (2008) [58] | 401 | Healthy middle-aged women | LOT | Metabolic syndrome | PR | −.03 |
Motivala et al. (1999) [8] | 25 | Type I and II diabetes | LOT | Disease duration | CS | −.41 |
Nelson et al. (2003) [59] | 982 | Pregnancy | LOT-R | Pregnancy loss | PR | .09 |
Raikkonen et al. (1999) [60] | 100 | Healthy people | LOT | Average systolic ambulatory blood pressure over 3 days | PR | .18 |
Raikkonen et al. (1999) [60] | 100 | Healthy people | LOT | Average diastolic ambulatory blood pressure over 3 days | PR | .26 |
Rini et al. (1999) [61] | 230 | Pregnancy | LOT | Birth weight | LO | .09 |
Rini et al. (1999) [61] | 230 | Pregnancy | LOT | Gestational age | LO | .01 |
Scheier et al. (1989) [36] | 51 | Coronary artery bypass surgery | LOT | Physical recovery | PR | .36 |
Scheier et al. (1989) [36] | 51 | Coronary artery bypass surgery | LOT | Fewer post-operative complications | PR | .23 |
Scheier et al. (1999) [13] | 263 | Coronary artery bypass surgery | LOT | Rehospitalization | PR | −.33 |
Schofield et al. (2004) [14] | 179 | Lung cancer | LOT | Survival | PR | .03 |
Schulz et al. (1996) [62] | 238 | Cancer | LOT (pessimism) | Mortality | PR | .14 |
Schulz et al. (1996) [62] | 238 | Cancer | LOT (optimism) | Mortality | PR | .04 |
Segerstrom (2001) [63] | 22 | Law students | LOT-R | Immune function (DTH skin test) | PR | .09 |
Segerstrom et al. (2003) [64] | 30 | Medical and Law students | LOT-R | Immune function (DTH skin test) | PR | .12 |
Segerstrom et al. (1998) [65] | 50 | Law students | LOT | Immune measure (CD4 helper T cells) | PR | .01 |
Segerstrom et al. (1998) [65] | 50 | Law students | LOT | Immune measure (CD8-cytotoxic T cells) | PR | .25 |
Segerstrom et al. (1998) [65] | 50 | Law students | LOT | Immune measure (CD19 B cells) | PR | .15 |
Segerstrom et al. (1998) [65] | 50 | Law students | LOT | Immune measure (CD16+56 natural killer cells) | PR | −.01 |
Tomakowsky et al. (2001) [66] | 78 | HIV/AIDS | LOT | Lower CD 4 counts | CS | −.05 |
Tomakowsky et al. (2001) [66] | 78 | HIV/AIDS | EASQ | Lower CD 4 counts | CS | −.21 |
Tomakowsky et al. (2001) [66] | 47 | HIV/AIDS | LOT | Decline in CD 4 counts at 2-year follow-up | PR | −.08 |
Tomakowsky et al. (2001) [66] | 47 | HIV/AIDS | EASQ | Decline in CD 4 counts at 2-year follow-up | PR | −.43 |
Von Ah and Kang (2007) [67] | 49 | Breast cancer | LOT-R | Disease stage at baseline | CS | −.06 |
Von Ah and Kang (2007) [67] | 49 | Breast cancer | LOT-R | Lymph node status at baseline | CS | −.02 |
Von Ah and Kang (2007) [67] | 49 | Breast cancer | LOT-R | Disease stage at post-treatment | CS | −.04 |
Von Ah and Kang (2007) [67] | 49 | Breast cancer | LOT-R | Lymph node status at post-treatment | CS | .02 |
Von Ah et al. (2007) [68] | 54 | Breast cancer | LOT-R | Immune measure (natural killer cells) | CS | .08 |
Yi et al. (2008) [69] | 111 | Diabetes mellitus | LOT | Glycosylated hemoglobin | LO | −.11 |
Studies with subjective health measure | ||||||
Abend and Williamson (2002) [70] | 63 | Breast cancer | LOT | Patient report of cancer recurrence | CS | −.12 |
Achat et al. (2000) [71] | 659 | Aging | LOT | Freedom from pain | LO | .06 |
Affleck et al. (2001) [1] | 89 | Fibromyalgia | LOT | Mean daily pain | LO | −.04 |
Affleck et al. (2001) [1] | 89 | Fibromyalgia | LOT | Mean daily fatigue | LO | −.13 |
Allison et al. (2001) [72] | 88 | Head and neck cancer | FLOT | Freedom from pain | CS | .18 |
Baker (2007) [73] | 39 | Undergraduates | LOT (optimism) | Physical symptoms | LO | −.18 |
Baker (2007) [73] | 39 | Undergraduates | LOT (pessimism) | Physical symptoms | LO | .19 |
Bennett and Elliot (2005) [74] | 72 | Post-cardiac event | ASQ | Physical symptoms | LO | −.54 |
Bensten et al. (2008) [75] | 101 | Spinal fusion patients | One-item measure (pessimism) | Pain | CS | .57 |
Brewer (2007) [76] | 91 | Knee surgery | LOT-R | Knee pain | LO | .07 |
Chamberlain et al. (1992) [77] | 50 | Surgery | LOT | Knee pain | PR | −.14 |
Chaney et al. (2004) [78] | 42 | Rheumatoid arthritis | ASQ | Pain | LO | .34 |
Conway et al. (2008) [79] | 67 | Hypertension | LOT-R (optimism) | Physical symptoms | CS | −.25 |
Conway et al. (2008) [79] | 67 | Hypertension | LOT-R (pessimism) | Physical symptoms | CS | .46 |
Costello et al. (2002) [2] | 20 | Temporomandibular disorder | LOT | Pain | PR | −.02 |
Curbow et al. (1993) [80] | 135 | Bone marrow transplants | LOT | Perceived health | CS | .25 |
de Ridder et al. (2004) [5] | 50 | Multiple sclerosis | LOT-R | Physician rating of neurological disorder interfering with functioning | CS | −.11 |
de Ridder et al. (2004) [5] | 50 | Multiple sclerosis | LOT-R | Physical functioning | PR | .06 |
de Ridder et al. (2004) [5] | 65 | Type I diabetes | LOT-R | Physical functioning | PR | .24 |
Ferreira and Sherman (2007) [81] | 72 | Osteoarthritis | LOT-R | Pain | CS | −.28 |
Fitzgerald et al. (2000) [82] | 50 | Coronary artery bypass surgery | LOT | Reduction in post-CABG angina | LO | .29 |
Fotiadou et al. (2008) [83] | 100 | Parents of cancer patients | LOT-R | Perceived health | CS | .26 |
Fournier et al. (2002a) [6] | 269 | Chronic disease | LOT-R | Physical functioning at 6-month follow-up | LO | .24 |
Fournier et al. (2002a) [6] | 269 | Chronic disease | LOT-R | Physical functioning at 1-year follow-up | LO | .24 |
Fournier et al. (2002a) [6] | 269 | Chronic disease | LOT-R | Disease severity at 6-month follow-up | LO | −.22 |
Fournier et al. (2002a) [6] | 269 | Chronic disease | LOT-R | Disease severity at 1-year follow-up | LO | −.21 |
Fournier et al. (2002b) [7] | 104 | Type I diabetes | LOT-R | Patient report of physical functioning | CS | .15 |
Fournier et al. (2002b) [7] | 95 | Rheumatoid arthritis | LOT-R | Patient report of physical functioning | CS | .25 |
Fournier et al. (2002b) [7] | 98 | Multiple sclerosis | LOT-R | Patient report of physical functioning | CS | .33 |
Fournier et al. (2002b) [7] | 104 | Type I diabetes | LOT-R | Physical symptoms | CS | −.26 |
Fournier et al. (2002b) [7] | 95 | Rheumatoid arthritis | LOT-R | Physical symptoms | CS | −.36 |
Fournier et al. (2002b) [7] | 98 | Multiple sclerosis | LOT-R | Physical symptoms | CS | −.29 |
Fry (1995) [84] | 37 | Female executives | LOT | Physical symptoms | CS | −.44 |
Glazer et al. (2002) [9] | 46 | Cardiac patients | LOT | Physical symptoms | CS | −.43 |
Glazer et al. (2002) [9] | 46 | Cardiac patients | LOT | Physical symptoms at 3-month follow-up | LO | −.11 |
Hamid (1990) [85] | 75 | Undergraduates | LOT | Influenza symptoms | LO | −.24 |
Hooker et al. (1992) [86] | 51 | Alzheimer's caregivers | LOT | Perceived health | CS | .15 |
Jackson et al. (2002) [87] | 99 | Undergraduates | EASQ (pessimism) | Physical illness | PR | .25 |
King et al. (1998) [88] | 75 | Coronary artery bypass surgery | LOT | Angina | LO | 0 |
Kurdek and Siesky (1990) [10] | 48 | HIV/AIDS | LOT | Physical symptoms | CS | −.06 |
Lam et al. (2004) [89] | 367 | Breast cancer | CLOT | Physical symptoms | CS | −.25 |
Lau and Knardahl (2008) [90] | 1,946 | Healthy adults | One-item measure (optimism) | Perceived health | CS | .27 |
Lau and Knardahl (2008) [90] | 1,946 | Healthy adults | One-item measure (optimism) | Mean pain | CS | −.11 |
Lyons and Chamberlain (1994) [11] | 158 | Undergraduates | LOT | Perceived health | CS | .28 |
Lyons and Chamberlain (1994) [11] | 158 | Undergraduates | LOT | Upper respiratory illness (URI) symptoms | CS | −.23 |
Lyons and Chamberlain (1994) [11] | 158 | Undergraduates | LOT | Physical symptoms | CS | −.17 |
Lyons and Chamberlain (1994) [11] | 138 | Undergraduates | LOT at 2-week follow-up | Perceived health at 2-week follow-up | CS | .16 |
Lyons and Chamberlain (1994) [11] | 138 | Undergraduates | LOT at 2-week follow-up | URI symptoms at 2-week follow-up | CS | −.01 |
Lyons and Chamberlain (1994) [11] | 138 | Undergraduates | LOT at 2-week follow-up | Physical symptoms at 2-week follow-up | CS | −.08 |
Lyons and Chamberlain (1998) [91] | 175 | Undergraduates | LOT | URI symptoms | CS | −.20 |
Lyons and Chamberlain (1998) [91] | 175 | Undergraduates | LOT | Non-URI symptoms | CS | −.16 |
Lyons and Chamberlain (1998) [91] | 131 | Undergraduates | LOT | URI symptoms | LO | −.32 |
Lyons and Chamberlain (1998) [91] | 131 | Undergraduates | LOT | Non-URI symptoms | LO | −.21 |
Mahler and Kulik (2000) [3] | 215 | Coronary artery bypass surgery | LOT | Pain at 2 week post coronary artery bypass surgery | LO | −.21 |
Mahler and Kulik (2000) [3] | 215 | Coronary artery bypass surgery | LOT | Pain at 1 month post coronary artery bypass surgery | LO | −.17 |
Mahler and Kulik (2000) [3] | 215 | Coronary artery bypass surgery | LOT | Pain at 3 months post coronary artery bypass surgery | LO | −.14 |
Mahler and Kulik (2000) [3] | 215 | Coronary artery bypass surgery | LOT | Pain at 6 months post coronary artery bypass surgery | LO | −.17 |
Mahler and Kulik (2000) [3] | 215 | Coronary artery bypass surgery | LOT | Pain at 12 months post coronary artery bypass surgery | LO | −.27 |
Motivala et al. (1999) [8] | 25 | Type I and II diabetes | LOT | Physical symptoms | CS | −.47 |
Northouse et al. (1999) [12] | 98 | Breast cancer | LOT | Physical symptoms | CS | −.48 |
Pence (2007) [92] | 27 | Sickle cell patients | LOT-R | Mean pain | LO | .09 |
Pritchard et al. (2007) [93] | 242 | Undergraduates | LOT | Physical symptoms | PR | −.16 |
Pakenham and Rinaldis (2001) [94] | 114 | HIV/AIDS | LOT | Perceived health | CS | .07 |
Ruthig et al. (2007) [95] | 231 | Aging | LOT | Perceived health | CS | .33 |
Scheier et al. (1989) [36] | 51 | Coronary artery bypass surgery | LOT | Staff ratings of physical recovery | PR | .25 |
Scheier et al. (1989) [36] | 51 | Coronary artery bypass surgery | LOT | Angina | PR | −.29 |
Segerstrom (2007) [96] | 61 | Law students | LOT | Physical symptoms | LO | −.22 |
Shen et al. (2004) [97] | 149 | Post-cardiac event | LOT-R | Physical health at 6-week follow-up | LO | .49 |
Shepperd et al. (1996) [98] | 22 | Cardiac patients | LOT | Decrease in global coronary risk (self-report) | LO | .64 |
Shnek et al. (2001) [99] | 86 | Cardiac patients | LOT | Chest pain | CS | −.29 |
Smets et al. (1998) [100] | 250 | Cancer | LOT | Fatigue | CS | −.01 |
Smets et al. (1998) [100] | 250 | Cancer | LOT | Fatigue at 2-week follow-up | LO | .03 |
Smets et al. (1998) [100] | 250 | Cancer | LOT | Fatigue at 9-month follow-up | LO | .08 |
Smith and Zautra (2004) [4] | 64 | Knee surgery | LOT-R | Pain | CS | .11 |
Smith and Zautra (2004) [4] | 64 | Knee surgery | LOT-R | Pain | PR | −.02 |
Tallman et al. (2007) [101] | 56 | Cancer | LOT | Physical functioning | LO | .42 |
Tennen et al. (1992) [102] | 54 | Rheumatoid arthritis | LOT | Pain | CS | −.27 |
Tennen et al. (1992) [102] | 54 | Rheumatoid arthritis | LOT | Disease activity | CS | −.09 |
Treharne et al. (2007) [103] | 117 | Rheumatoid arthritis | LOT (optimism) | Pain | LO | .01 |
Treharne et al. (2007) [103] | 117 | Rheumatoid arthritis | LOT (pessimism) | Pain | LO | .23 |
Treharne et al. (2007) [103] | 117 | Rheumatoid arthritis | LOT (optimism) | Fatigue | LO | −.05 |
Treharne et al. (2007) [103] | 117 | Rheumatoid arthritis | LOT (pessimism) | Fatigue | LO | .14 |
Tomakowsky et al. (2001) [66] | 78 | HIV/AIDS | LOT | HIV symptoms | CS | −.30 |
Tomakowsky et al. (2001) [66] | 78 | HIV/AIDS | EASQ | HIV symptoms | CS | −.28 |
Treharne et al. (2005) [104] | 154 | Rheumatoid arthritis | LOT | Pain/fatigue | CS | −.13 |
Treharne et al. (2001) [105] | 125 | Undergraduates | LOT | URI symptoms | LO | −.04 |
Umstattd et al. (2007) [106] | 231 | Older women | LOT-R (optimism) | Physical functioning | CS | −.13 |
Umstattd et al. (2007) [106] | 231 | Older women | LOT-R (pessimism) | Physical functioning | CS | .20 |
Wong and Fielding (2007) [107] | 144 | Lung cancer patients | Single item optimism measure | Pain | LO | −.03 |
Wyatt et al. (1999) [108] | 699 | Cancer | LOT | Physical symptoms | CS | −.21 |
LOT Life Orientation Test (Scheier and Carver [18]), LOT-R Life Orientation Test-Revised (Scheier et al. [19]), FLOT French life orientation test (Allison et al. [109]), CLOT Chinese life orientation test (Lai et al. [110]); ASQ Attributional Style Questionnaire (Peterson et al. [21]), EASQ Expanded Attributional Style Questionnaire (Peterson and Vallanova [22]), TC Terman cheerfulness (Friedman et al. [47]), SWB Dutch subjective well-being for older persons (Tempelman [111]), CS cross-sectional, LO longitudinal; PR prospective